塔拉他马布用于小细胞肺癌
Sabina Antoniu1, Theodor Penisoara2, Stefan Rascu3
1Department of Medicine II-Nursing, University of Medicine and Pharmacy, Grigore T Popa, Iasi, Romania.
Expert opinion on biological therapy
|December 16, 2025
概括
塔拉塔马布是广泛小细胞肺癌 (SCLC) 的有效双特异性抗体,特别是在复发或进展的病例中. 在有限的SCLC中,单独或组合的进一步评估得到了当前数据的支持.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 小细胞肺癌 (SCLC) 是一种侵略性的恶性瘤,通常表达DLL3.
- 塔拉他马布是一种针对DLL3的双特异性抗体,旨在阻止下游途径并增强抗瘤免疫力.
研究的目的:
- 审查tarlatamab的药理学和临床数据.
- 评估tarlatamab在各种SCLC环境中的疗效.
主要方法:
- 对tarlatamab. 的现有药理和临床试验数据的审查.
- 分析主要来自SCLC患者的数据,同时考虑早期发育中的其他征兆.
主要成果:
- 塔拉塔马布显示出有效性,特别是在复发或进展的广泛SCLC.
- 这种药物目前在美国被授权用于广泛的SCLC治疗.
结论:
- 塔拉塔马布是复发性/进展性SCLC的有价值的治疗选择.
- 现有的数据支持进一步调查tarlatamab在有限的SCLC中,作为单疗法或组合治疗.
关键词:
在BITE抗体中.在 DLL3 中,你会看到 DLL3 文件.细胞因子释放综合征 细胞因子释放综合征免疫效应细胞疗法相关的神经毒性综合征小细胞肺癌是一种小细胞肺癌.塔拉塔塔马巴巴巴巴巴巴巴巴巴巴巴 巴巴巴巴巴巴巴更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.8K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
